Prostate Cancer Information

Return to Previous Page

Prostate Cancer & the Man You Love

by Anne Katz, RN, PhD

So you’ve been with this same man for 10 or 20 or even 50 years and you each know how the other thinks, right? Per­haps at times you even say the exact same thing at the exact same time and you both laugh at how well you know each other. But when illness occurs, those automatic and familiar ways of communicating often don’t work any longer or as effectively. Times of crisis require great communication, not just good communication; these times re­quire the use of words rather than looks or telepathy.

Read More


A Team Approach to Treating Prostate Cancer

by Alan M. Nieder, MD, and Rafael Yanes, MD

Prostate cancer is the most common non-skin-related cancer for American men. The American Cancer Society estimates that nearly 240,000 men will be diagnosed with prostate cancer this year. While prostate cancer can be aggressive, most men are diagnosed at an early and cur­able stage. Additionally, most newly diagnosed men have no signs or symptoms of prostate cancer and feel perfectly well. They are typically only diagnosed because they have had a PSA blood test that prompted a prostate biopsy.

Read More


FDA Approves New Drug for Advanced Prostate Cancer

The U.S. Food and Drug Administration has approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone.

Read More


Updated Tool Now Available to Predict Prostate Cancer Spread

Prostate cancer experts at Johns Hopkins Hospital in Baltimore, MD, have developed an updated version of the Partin Tables, a tool to help men diagnosed with prostate cancer and their doctors to better assess their chance of a surgical cure. The updated tool is published in the British Journal of Urology International. This represents the third update of the data.

Read More


What You Need to Know about Urinary Incontinence after Prostate Cancer Treatment

by Jeffrey Albaugh, PhD, APM, CUCNS

Men treated for prostate cancer know that when the catheter comes out, the leakage may begin. For many men, this leakage may resolve over the next year, but for some men, the issue may last longer. Research reveals approximately 15 percent of men are incontinent up to one year following either radical prostatectomy or laparoscopic prostatectomy. It can take as long as two years for men to regain urinary continence.

Read More


Above-the-Belt Relationship Changes That Can Come with Prostate Cancer

by Arnold Melman, MD, and Rosemary E. Newnham

Although many men see their temporary or permanent loss of erectile function as the chief change that affects their relationships post-treatment, most researchers would argue that the bigger changes happen – and need to happen – above the belt buckle: in the brain and in the heart.

Read More


FDA Expands Zytiga’s Use for Late-stage Prostate Cancer

The U.S. Food and Drug Administration has expanded the approved use of Zytiga® (abiraterone acetate) to treat men with late-stage (metastatic) castration-resistant prostate cancer prior to receiving chemotherapy.

Read More


Prostate Cancer Affects Women, Too

by Cindie Hubiak

Our society considers prostate cancer solely a man’s disease. It’s not. Prostate cancer can affect women physically, emotionally, and spiritually. To complicate matters further, many men don’t want anyone to know about their diagnosis and treatment. This vow of silence reduces potential resources for women, pushing the topic under a rug, causing many of us to feel suffocated and isolated.

Read More


Page 2 of 7  < 1 2 3 4 >  Last ›


eUpdate Sign up

Receive e-mails with links to the latest content on the Coping with Cancer website.

See past issues of eUpdate.

Follow us on Twitter

          Twitter icon

Like us on Facebook

          FaceBook icon

Subscribe to
Coping with Cancer magazine